medicine for ovarian cancer - Page 8 of 33

ONCOTAXEL 260MG INJ

ONCOTAXEL 260MG INJ is a Schedule H drug. ONCOTAXEL 260MG INJ is composed of: PACLITAXEL (260.0 MG)

ONCOTAXEL 100MG INJ is a Schedule H drug. ONCOTAXEL 100MG INJ is composed of: PACLITAXEL (100.0 MG)

ONCOPLATIN AQ 50MG INFUSION is a Schedule H drug. ONCOPLATIN AQ 50MG INFUSION is composed of: CISPLATIN (50.0 MG)

ONCOPLATIN AQ 10MG INJ is a Schedule H drug. ONCOPLATIN AQ 10MG INJ is composed of: CISPLATIN (10.0 MG)

ONCOGEM 1.4GM INJ is a Schedule H drug. ONCOGEM 1.4GM INJ is composed of: GEMCITABINE (1.4 GM)

NEOTAXL 260MG INJ is a Schedule H drug. NEOTAXL 260MG INJ is composed of: PACLITAXEL (260.0 MG)

NEOTAXL 100MG INJ is a Schedule H drug. NEOTAXL 100MG INJ is composed of: PACLITAXEL (100.0 MG)

NEODREA 500MG CAP is a Schedule H drug. NEODREA 500MG CAP is composed of: HYDROXYUREA (500.0 MG)

NANOXEL 30MG INJ is a Schedule H drug. NANOXEL 30MG INJ is composed of: PACLITAXEL (30.0 MG)

NANOXEL 300MG INJ is a Schedule H drug. NANOXEL 300MG INJ is composed of: PACLITAXEL (300.0 MG)